Abstract
Aim: To evaluate the effect of implementation of a hysterectomy Enhanced Recovery After Surgery (ERAS) protocol on perioperative anesthetic medication costs. Patients & methods: Historical cohort study of 84 adult patients who underwent a hysterectomy. Forty-two patients who underwent surgery before protocol implementation comprised the pre-ERAS group. Forty-two patients who underwent surgery after protocol implementation comprised the post-ERAS group. Data on anesthetic medication costs and outcomes were analyzed. Results: Compared with the pre-ERAS group, the post-ERAS group's total medication cost was significantly lower (median: 325.20 USD; interquartile range [IQR]: 256.12-430.65 USD vs median: 273.10 USD; IQR: 220.63-370.59 USD, median difference:-40.76, 95% CI:-130.39, 16.99, p = 0.047). Length of stay was significantly longer in pre-ERAS when compared with post-ERAS groups (median: 5.0 days; IQR: 4.0-7.0 days vs median: 3.0 days; IQR: 3.0-4.0 days, median difference:-2.0 days, 95% CI:-2.5581,-1.4419, p < 0.0001). Conclusion: ERAS protocols may reduce perioperative medication costs.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1067-1077 |
| Number of pages | 11 |
| Journal | Journal of Comparative Effectiveness Research |
| Volume | 9 |
| Issue number | 15 |
| DOIs | |
| State | Published - Oct 15 2020 |
Keywords
- anesthesia
- cost savings
- drug costs
- economics
- perioperative care
- pharmaceutical
ASJC Scopus subject areas
- Health Policy